Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering GlobeNewswire July 01, 2025 FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the pricing of an underwritten […]